Drugs Containing Excipient (Inactive Ingredient) POLYETHYLENE GLYCOL 2000

Branded drugs containing POLYETHYLENE GLYCOL 2000 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Supernus Pharmaceuticals Inc	OXTELLAR XR	oxcarbazepine	17772-121	POLYETHYLENE GLYCOL 2000
Pfizer Laboratories Div Pfizer Inc	AZULFIDINE	sulfasalazine	0013-0102	POLYETHYLENE GLYCOL 20000
ANI Pharmaceuticals Inc	LIPOFEN	fenofibrate	62559-305	POLYETHYLENE GLYCOL 20000
Kowa Pharmaceuticals America Inc	LIPOFEN	fenofibrate	66869-137	POLYETHYLENE GLYCOL 20000

Generic drugs containing POLYETHYLENE GLYCOL 2000 excipient

Company	Ingredient	NDC	Excipient
Blenheim Pharmacal, Inc.	diclofenac sodium	10544-188	POLYETHYLENE GLYCOL 2000
Blenheim Pharmacal, Inc.	diclofenac sodium	10544-189	POLYETHYLENE GLYCOL 2000
Supernus Pharmaceuticals Inc	oxcarbazepine	17772-121	POLYETHYLENE GLYCOL 2000
Rebel Distributors Corp	diclofenac sodium	42254-059	POLYETHYLENE GLYCOL 2000

Market Dynamics and Financial Trajectory for Polyethylene Glycol 2000

Last updated: March 1, 2026

What Are the Market Drivers for Polyethylene Glycol 2000 (PEG 2000)?

PEG 2000 is a high molecular weight polyethylene glycol used extensively in pharmaceutical formulations as a laxative, solvent, excipient, and drug delivery platform. Market growth is driven by the following factors:

• Rising demand for targeted drug delivery systems, where PEG 2000 enhances bioavailability and stability.
• Increase in pharmaceutical R&D investment, particularly in biologics and formulations requiring PEGylation.
• Growing prevalence of gastrointestinal and autoimmune disorders, increasing demand for laxatives and drug excipients.
• Regulatory acceptance, with approvals for PEG derivatives in both prescription and over-the-counter drugs.

What Is the Current Market Size and Forecast?

The global PEG 2000 market was valued at approximately USD 600 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 6.5% over the next five years, reaching USD 887 million by 2027. Major regional contributions include:

Region	Market Share (2022)	Projected CAGR (2023-2027)	Notes
North America	35%	6.2%	Driven by biotech sector and high R&D activity
Europe	28%	6.8%	Stringent regulatory environment fosters excipient use
Asia-Pacific	25%	7.5%	Rapid pharmaceutical manufacturing expansion
Rest of the World	12%	5.8%	Emerging markets, increasing access to healthcare

Who Are Key Market Players and Their Strategies?

Leading companies include:

• BASF SE
• Dow Inc.
• Ashland Global Holdings Inc.
• Merck KGaA
• Anhui Renheitian Pharmaceutical Co., Ltd.

Strategies include:

• Expansion of manufacturing capacity to meet rising demand.
• Development of PEG derivatives with enhanced safety profiles.
• Strategic partnerships with pharmaceutical companies for R&D collaborations.
• Focus on sustainable production processes to reduce environmental impact.

How Do Regulatory Policies Affect Market Trajectory?

Regulatory frameworks shape market dynamics through:

• Approvals for PEG-based formulations by agencies such as FDA, EMA.
• Revisions of safety guidelines for PEG derivatives, influencing manufacturing practices.
• Harmonization of standards, simplifying international trade.
• Increased scrutiny on PEG’s toxicity at high doses, which may impact demand in specific applications.

What Are Historical and Projected Financial Trends?

The financial trajectory indicates consistency in revenue growth aligned with market expansion. Key financial metrics include:

• Revenue growth from approximately USD 600 million in 2022 to USD 887 million in 2027.
• EBITDA margins typical of excipients suppliers range between 15% and 25%.
• Investment in capacity and R&D correlates with anticipated margin improvements and product diversification.

Year	Revenue (USD million)	Growth Rate	EBITDA Margin	Key Events
2022	600	—	20%	Established production, moderate growth
2023	640	+6.7%	20.5%	New capacity in Asia-Pacific
2024	680	+6.3%	21%	Launch of PEG derivatives
2025	725	+6.6%	22%	Strategic partnerships
2026	770	+6.2%	22.5%	Regulatory approvals increase
2027	887	+15.3%	23%	Market expansion, new applications

What Are the Challenges and Risks?

• Regulatory hurdles over PEG safety, particularly at high doses or in sensitive populations.
• Competition from alternative excipients with similar functionality.
• Supply chain disruptions, especially for raw materials like ethylene oxide.
• Environmental concerns related to manufacturing processes, prompting shifts toward greener methods.

---

Key Takeaways

• The market for PEG 2000 is expanding steadily, driven by pharmaceutical applications, with projected revenue reaching USD 887 million by 2027.
• North America and Europe dominate the market, but Asia-Pacific offers the fastest growth.
• Innovation in PEG derivatives and capacity expansion are central strategies for major players.
• Regulatory policies influence market dynamics significantly, impacting product development and commercialization.
• Financial growth aligns with production scaling, R&D investments, and utilization in new therapeutic areas.

---

FAQs

1. What segments of the pharmaceutical industry are most reliant on PEG 2000?
Biologics and drug delivery systems, especially PEGylated proteins and peptides, rely heavily on PEG 2000.

2. How does the regulatory environment affect new PEG 2000 manufacturing plants?
Strict safety and quality standards require extensive testing and approval, delaying time to market but ensuring product safety.

3. What are the main alternatives to PEG 2000?
Polyvinylpyrrolidone (PVP), poloxamers, and other synthetic polymers serve as substitutes in certain applications.

4. How is environmental sustainability impacting PEG 2000 production?
Pressure to reduce emissions and waste has prompted manufacturers to adopt greener synthesis methods, possibly increasing costs initially.

5. Will increased PEG safety concerns hamper market growth?
Potentially, but ongoing research and regulatory guidance are expected to mitigate risks, maintaining overall growth momentum.

---

References

[1] MarketsandMarkets. (2022). Polyethylene Glycol (PEG) Market by Molecular Weight, Application, and Region. Retrieved from https://www.marketsandmarkets.com.

[2] U.S. Food and Drug Administration. (2021). Guidance for Industry: PEG-containing medicinal products. Retrieved from https://www.fda.gov.

[3] Smith, J., & Lee, K. (2020). Trends in Pharmaceutical Excipients. Pharmaceutical Technology. 44(9), 38-45.